HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
magnesium carbonate drug combination aluminium hydroxide
antacid suspension; consists of magnesium carbonate, aluminum hydroxide & magnesium hydroxide
Also Known As:
aluminium hydroxide, magnesium carbonate drug combination; Balancid; Novaluzid; aluminium hydroxide - magnesium carbonate
Networked:
4
relevant articles (
0
outcomes,
2
trials/studies)
Bio-Agent Context: Research Results
Inorganic Chemicals: 9
Metals: 20694
Light Metals
Magnesium: 12037
magnesium carbonate drug combination aluminium hydroxide: 4
Elements: 18681
Alkaline Earth Metals: 20
Magnesium: 12037
magnesium carbonate drug combination aluminium hydroxide: 4
Light Metals
Magnesium: 12037
magnesium carbonate drug combination aluminium hydroxide: 4
Electrolytes: 16106
Ions: 7857
Anions: 3501
Hydroxides: 68
Aluminum Hydroxide: 502
magnesium carbonate drug combination aluminium hydroxide: 4
Magnesium Hydroxide: 104
magnesium carbonate drug combination aluminium hydroxide: 4
Alkalies: 2312
Hydroxides: 68
Aluminum Hydroxide: 502
magnesium carbonate drug combination aluminium hydroxide: 4
Magnesium Hydroxide: 104
magnesium carbonate drug combination aluminium hydroxide: 4
Aluminum Compounds: 21
Aluminum Hydroxide: 502
magnesium carbonate drug combination aluminium hydroxide: 4
Magnesium Compounds: 14
Magnesium Hydroxide: 104
magnesium carbonate drug combination aluminium hydroxide: 4
Pharmaceutical Preparations
Drug Combinations: 5337
magnesium carbonate drug combination aluminium hydroxide: 4
Related Diseases
1.
Ulcer
01/01/1985 - "
One hundred and nineteen patients with endoscopically confirmed prepyloric (n = 59) or duodenal (n = 60) ulcer were stratified for ulcer location before entering a randomized double-blind trial comparing ranitidine (150 mg twice daily) and a potent liquid antacid (Novaluzid; 10 ml seven times daily, with a neutralizing capacity of 600 mmol H+).
"
03/01/1988 - "
Patients with duodenal ulcer (DU; n = 79) or prepyloric ulcer (PPU; n = 39) received cimetidine, 400 mg twice daily, or Novaluzid, 10 ml four times daily (acid-neutralizing capacity, 340 mmol/day), in a multicentre, randomized, double-blind trial.
"
2.
Duodenal Ulcer (Curling's Ulcer)
03/01/1988 - "
Patients with duodenal ulcer (DU; n = 79) or prepyloric ulcer (PPU; n = 39) received cimetidine, 400 mg twice daily, or Novaluzid, 10 ml four times daily (acid-neutralizing capacity, 340 mmol/day), in a multicentre, randomized, double-blind trial.
"
3.
Pain (Aches)
05/01/1985 - "
Statistical analyses based both on the 37 completers and on the 43 patients who had at least two treatment periods showed that ranitidine and Novaluzid were superior to placebo with regard to pain score (p less than 0.005) but not with regard to regurgitation, dysphagia, histology, and appearance on endoscopy (p greater than 0.05).
"
4.
Gastroesophageal Reflux (GERD)
05/01/1985 - "
The liquid antacid Novaluzid (10 ml seven times daily) was compared with ranitidine (150 mg twice daily) and with placebo in 57 patients with symptoms and endoscopic signs of oesophagitis and gastro-oesophageal reflux.
"
5.
Fibrosis (Cirrhosis)
01/01/1986 - "
If a mixture of aluminium hydroxide, magnesium carbonate and oxethazaine was added to the aspirate, development of lung fibrosis was prevented, but severe granulomatous reaction with foreign body giant cells within both lungs evolved.
"
Related Drugs and Biologics
1.
Ranitidine (Zantac)
2.
Antacids
3.
Cimetidine (Biomet)
4.
Acids
5.
oxethazaine